 |
5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol |
|---|---|
| Trade Name | Resveratrol |
| Orphan Indication | Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes |
| USA Market Approval | USA |
| USA Designation Date | 2008-03-13 00:00:00 |
| Sponsor | Sirtris Pharmaceuticals, Inc.;200 Technology Square;Cambridge, Massachusetts, 02139 |
